Omori Rui, Gonda Kenji, Arai Megumi, Sawano Toyoaki, Kurokawa Tomohiro, Tamada Yutaka, Yasui Ayu, Nashinoto Mika, Wada Masahiro, Tachibana Kazunoshin, Tanimoto Tetsuya, Shimmura Hiroaki, Ohtake Tohru, Ozaki Akihiko
Breast and Thyroid Center, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan.
Department of Nursing, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan.
Case Rep Oncol. 2025 Apr 26;18(1):721-727. doi: 10.1159/000546095. eCollection 2025 Jan-Dec.
Contraceptive counseling for cancer patients, especially during periods of treatment-induced amenorrhea, is often overlooked. This can lead to unexpected pregnancies with significant implications for patient care and outcomes.
We report a case of a 38-year-old BRCA2-positive breast cancer patient who experienced an unexpected twin pregnancy while undergoing treatment with tamoxifen and olaparib. The patient had been amenorrheic since initiating chemotherapy for more than 600 days and had not received contraceptive counseling. The pregnancy was discovered during routine follow-up imaging computed tomography. After thorough counseling regarding the teratogenic potential of her treatments and radiation exposure, and considering the patient's strong desire to prioritize her own treatment to safeguard her existing three children, the pregnancy was terminated.
This case highlights the need for comprehensive contraceptive counseling throughout cancer treatment, regardless of apparent fertility status. It also emphasizes the importance of considering both teratogenicity of treatments and patients' personal circumstances in managing unexpected pregnancies in cancer patients.
癌症患者的避孕咨询,尤其是在治疗导致闭经期间,常常被忽视。这可能导致意外怀孕,对患者护理和治疗结果产生重大影响。
我们报告一例38岁的BRCA2阳性乳腺癌患者,她在接受他莫昔芬和奥拉帕利治疗期间意外怀了双胞胎。该患者自开始化疗后闭经已超过600天,且未接受过避孕咨询。此次怀孕是在常规随访的计算机断层扫描成像中发现的。在就其治疗的致畸潜力和辐射暴露进行全面咨询后,并考虑到患者强烈希望优先进行自身治疗以保护她现有的三个孩子,此次怀孕被终止。
该病例凸显了在整个癌症治疗过程中进行全面避孕咨询的必要性,无论患者表面的生育状况如何。它还强调了在处理癌症患者意外怀孕时,既要考虑治疗的致畸性,又要考虑患者个人情况的重要性。